Here, we demonstrated that neurogenic compound P7C3 could inhibit glioma malignant progression in vitro and in vivo by regulating aerobic glycolysis via directly targeting PGK1, which leads to declined energy supply. Here, PGK1 is linked to central nervous system cancer.